Preparation of Meiotic Chromosome Spreads from Mouse Oocytes for Assessment of Synapsis and Recombination
July 18th, 2025
1.9K views
Figure 1: End-to-end framework. The figure illustrates end-to-end framework for multimodal knowledge Graph VISHAM-KG. Please click here to view a larger v
| Distance to plane | Ion beam current | Stage tilt adjustment |
| > 3 µm | 30 kV / 0.5 nA | +1° (above) / −1° (below) |
| 2–3 µm | 30 kV / 0.3 nA | +1° / −1° |
| 1–2 µm | 30 kV / 0.1 nA | ±0.5° |
| 0.5-1.0 µm | 30 kV / 50 pA | ±0.3° |
| <0.5 µm | 30 kV / 50 pA | ±0.2° |
View the full transcript and gain access to thousands of scientific videos
Overview
The article presents an end-to-end framework for the multimodal knowledge graph VISHAM-KG. This framework integrates various data modalities to enhance knowledge representation and retrieval.
Key Study Components
Area of Science
- Neuroscience
- Data Science
- Knowledge Graphs
Background
- Knowledge graphs are essential for organizing complex data.
- Multimodal data integration improves knowledge representation.
- VISHAM-KG aims to facilitate better data accessibility.
- The framework supports various research applications.
Purpose of Study
- To develop a comprehensive framework for multimodal knowledge integration.
- To enhance the usability of knowledge graphs in research.
- To provide a visual representation of the framework.
Methods Used
- Framework design and implementation.
- Integration of multimodal data sources.
- Visualization techniques for knowledge representation.
- Evaluation of framework effectiveness.
Main Results
- The VISHAM-KG framework successfully integrates multiple data modalities.
- Enhanced knowledge retrieval capabilities were demonstrated.
- Visualizations provided clear insights into data relationships.
- User feedback indicated improved accessibility of information.
Conclusions
- The VISHAM-KG framework represents a significant advancement in knowledge graph technology.
- Future research can build upon this framework for various applications.
- Continued development is necessary to refine integration techniques.
Frequently Asked Questions
What is VISHAM-KG?
VISHAM-KG is a multimodal knowledge graph framework designed to integrate various data sources for enhanced knowledge representation.
How does the framework improve data accessibility?
By integrating multiple modalities, VISHAM-KG allows for more comprehensive data retrieval and visualization, making information easier to access.
What are the main applications of VISHAM-KG?
The framework can be applied in various research fields where data integration and knowledge representation are critical.
What visualization techniques are used in the framework?
The framework employs advanced visualization techniques to illustrate data relationships and enhance user understanding.
What feedback was received from users?
Users reported improved accessibility and usability of information through the VISHAM-KG framework.
Executive Industry Relevance
Accurate assessment of meiotic chromosome synapsis and recombination in mouse oocytes is critical for understanding mechanisms underlying chromosomal segregation errors, which directly impact reproductive health and genetic stability. This protocol enables quantitative evaluation of crossover formation and synapsis, supporting early discovery efforts to de-risk targets involved in meiotic regulation. The approach provides foundational data for translational research into infertility and aneuploidy, informing portfolio decisions in reproductive biology and genetic disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of genes and pathways regulating meiotic recombination and synapsis.
- Supports biological de-risking by quantifying crossover frequency and synaptic integrity.
- Provides mechanistic insight for target validation in reproductive and genetic disease research.
Screening & Assay Development
- Establishes validated immunofluorescence markers for robust detection of recombination and synapsis events.
- Facilitates standardization of chromosome spread assays for reproducible quantitative outputs.
- Prepares biological systems for downstream screening of modulators affecting meiotic processes.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints such as aneuploidy and infertility phenotypes.
- Enables continuity from mechanistic discovery to preclinical validation of candidate interventions.
- Supports risk-adjusted advancement of targets implicated in chromosomal segregation fidelity.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by providing quantitative readouts of meiotic chromosome dynamics, supporting both hypothesis testing and translational alignment.
- Discovery Biology: Quantifies synapsis and crossover formation to clarify pathway function and de-risk targets.
- Screening: Delivers reproducible immunofluorescence-based assays for comparative analysis of genetic or pharmacological perturbations.
- Analytics: Provides quantitative measurements of bivalents, chiasmata, and marker localization for robust statistical analysis.
- Translational Research: Links early mechanistic findings to phenotypes relevant for preclinical reproductive models.
- Enterprise Reuse: Offers a standardized platform adaptable across genetic backgrounds and experimental conditions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target selection by directly measuring meiotic outcomes.
- Operational Value: Enhances reproducibility and scalability through standardized chromosome spread and staining protocols.
- Strategic Value: Informs go/no-go decisions by providing early quantitative evidence of target impact on chromosomal integrity.
- Portfolio Impact: Supports risk-adjusted prioritization of reproductive and genetic disease programs.
Implementation Considerations
- Requires expertise in oocyte isolation, chromosome spreading, and immunofluorescence microscopy.
- Demands access to high-quality imaging and quantitative analysis infrastructure.
- Necessitates cross-team standardization of assay conditions and marker selection.
- Adaptable to various mouse strains and developmental stages with protocol optimization.
- Potential limitations include variability in oocyte yield and technical sensitivity of spread preparation.
Biopharma FAQs
Why does null hypothesis testing matter for synapsis marker analysis?
Null hypothesis testing enables objective evaluation of whether observed differences in synapsis marker localization are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit chromosome spread workflows?
Isolating variables such as genetic background or treatment condition ensures that changes in synapsis or recombination markers reflect true biological effects, strengthening mechanistic confidence in discovery-stage findings.
What do quantitative crossover counts enable in preclinical research?
Quantitative measurement of crossovers and bivalents provides actionable endpoints for comparing genetic or pharmacological interventions, enabling data-driven advancement decisions in reproductive biology pipelines.
Why are replication requirements critical for oocyte spread assays?
Replication across multiple oocytes and experimental runs ensures reproducibility and reliability of synapsis and recombination measurements, facilitating cross-functional collaboration and data integration.
Which statistical analysis capabilities are needed before protocol implementation?
Robust statistical tools are required to analyze marker localization, crossover frequency, and bivalent counts, enabling teams to distinguish true biological effects from technical variability and inform portfolio decisions.
